Experimental Sample Clauses

Experimental. Shall be defined as all procedures and treatments not covered under the Medicare Program (Title XVlll of Social Security Act of 1965, as amended), unless otherwise specifically included or excluded under this Agreement.

Experimental. INVESTIGATIVE - the use of any treatment, Service, procedure, facility, equipment, drug, device or supply (intervention) which is not determined by the Plan to be medically effective for the condition being treated. The Plan will consider an intervention to be Experimental/Investigative if: a. the intervention does not have FDA approval to be marketed for the specific relevant indication(s); or b. available scientific evidence does not permit conclusions concerning the effect of the intervention on health outcomes; or c. the intervention is not proven to be as safe and as effective in achieving an outcome equal to or exceeding the outcome of alternative therapies; or d. the intervention does not improve health outcomes; or e. the intervention is not proven to be applicable outside the research setting. If an intervention as defined above is determined to be Experimental/Investigative at the time of Service, it will not receive retroactive coverage even if it is found to be in accordance with the above criteria at a later date.

Experimental. Materials and reagents Physical measurements

Experimental. The Seebeck coefficient was measured using a home-made sample holder built on a PPMS puck. It consists of two copper blocks separated by a thermal insulator plastic. The copper has a high thermal conductance so the blocks are at a uniform temperature while a temperature gradient is produced be- tween them. A small heater (maximum power of 5 W) is installed in the upper block. Its temperature is measured with a Pt-100 resistor and controlled with an external temperature controller. The temperature of the lower block is controlled by the set point of the PPMS, but the temperature was separately measured by a second Pt-100 resistor. The whole setup is covered with a stainless steal cup that isolates the sample holder to help stabilize the tem- perature gradient. The measurements were done in a relatively low vacuum of 10 mTorr. A schematic of the sample holder is given in Fig.6.1 The samples consisted of thin films, mostly on sapphire substrates, with an area of 10 × 10 mm2. CrO2 films were deposited by Chemical Vapor Deposition (CVD) on both isostructural TiO2(100) and sapphire (1000) sub- strates. CrO2 films deposit epitaxially on TiO2 in the form of rectangular grains aligned along c-axis but on sapphire the grains are aligned with six fold rotational symmetry coming from the hexagonal structure of the substrate, as detailed in Chapter 3. The Py thin films were deposited using dc sputter- ing in a UHV sputtering system, with a base pressure of 10−9 mbar, the Co films were deposited in Z-400 an RF sputtering system with base pressure of 10−6 mbar. Both Py and Co were deposited on sapphire substrates because of its better thermal conductivity. The Seebeck coefficient was recorded with reference to copper since Cu wires were connected at both ends of the film via pressed Indium. The po- tential difference was probed using a Nanovoltmeter (▇▇▇▇▇▇▇▇ 2018) in an open circuit geometry (J = 0). A dynamic technique was utilized to measure TEM as function of temperature in which the temperature difference between hot and cold point was always 5 K, while the temperature of the cold point was increased by 10 K in each step. In this way hot point and cold point interchanged in each step between the temperature range of 100 - 400 K [80]. To check the setup, TEP was measured for nonmagnetic Cu, Au, and Pt with reference to Cu. In principal, it should give a zero TEP on a Cu thin film, but we measured around 2.5 µV at temperature difference of 45 K with the hot terminal b...

Experimental. PLAN The experimental details that follow are approximate and may be changed upon mutual agreement of the NCI and Kite. Any change in the scope of this CRADA will be by mutual consent and written Amendment to the CRADA. […***…]. […***…]. PHS ICT-CRADA Case Ref. No. MODEL ADOPTED June 18, 2009 Page 28 of 52 Confidential PUBLIC HEALTH SERVICE COOPERATIVE RESEARCH AND DEVELOPMENT AGREEMENT FOR INTRAMURAL-PHS CLINICAL RESEARCH […***…]. PHS ICT-CRADA Case Ref. No. MODEL ADOPTED June 18, 2009 Page 29 of 52 Confidential PUBLIC HEALTH SERVICE COOPERATIVE RESEARCH AND DEVELOPMENT AGREEMENT FOR INTRAMURAL-PHS CLINICAL RESEARCH […***…]. PHS ICT-CRADA Case Ref. No. MODEL ADOPTED June 18, 2009 Page 30 of 52 Confidential PUBLIC HEALTH SERVICE COOPERATIVE RESEARCH AND DEVELOPMENT AGREEMENT FOR INTRAMURAL-PHS CLINICAL RESEARCH […***…]. PHS ICT-CRADA Case Ref. No. MODEL ADOPTED June 18, 2009 Page 31 of 52 Confidential PUBLIC HEALTH SERVICE COOPERATIVE RESEARCH AND DEVELOPMENT AGREEMENT FOR INTRAMURAL-PHS CLINICAL RESEARCH […***…]. PHS ICT-CRADA Case Ref. No. MODEL ADOPTED June 18, 2009 Page 32 of 52 Confidential PUBLIC HEALTH SERVICE COOPERATIVE RESEARCH AND DEVELOPMENT AGREEMENT FOR INTRAMURAL-PHS CLINICAL RESEARCH […***…]. PHS ICT-CRADA Case Ref. No. MODEL ADOPTED June 18, 2009 Page 33 of 52 Confidential PUBLIC HEALTH SERVICE COOPERATIVE RESEARCH AND DEVELOPMENT AGREEMENT FOR INTRAMURAL-PHS CLINICAL RESEARCH […***…]. PHS ICT-CRADA Case Ref. No. MODEL ADOPTED June 18, 2009 Page 34 of 52 Confidential PUBLIC HEALTH SERVICE COOPERATIVE RESEARCH AND DEVELOPMENT AGREEMENT FOR INTRAMURAL-PHS CLINICAL RESEARCH […***…]. DESCRIPTION OF THE CONTRIBUTIONS AND RESPONSIBILITIES OF THE PARTIES — […***…]. PHS ICT-CRADA Case Ref. No. MODEL ADOPTED June 18, 2009 Page 35 of 52 Confidential PUBLIC HEALTH SERVICE COOPERATIVE RESEARCH AND DEVELOPMENT AGREEMENT FOR INTRAMURAL-PHS CLINICAL RESEARCH — […***…]. — […***…]. — […***…]. PHS ICT-CRADA Case Ref. No. MODEL ADOPTED June 18, 2009 Page 36 of 52 Confidential PUBLIC HEALTH SERVICE COOPERATIVE RESEARCH AND DEVELOPMENT AGREEMENT FOR INTRAMURAL-PHS CLINICAL RESEARCH — […***…]. RELATED NCI AND COLLABORATOR AGREEMENTS: NONE RELATED INTELLECTUAL PROPERTY AND BUSINESS/SCIENTIFIC EXPERTISE OF THE PARTIES

Experimental. 2.1 High pressure laminar flow reactor 2.2 High pressure jet-stirred reactor

Experimental. An apparatus was designed for carrying out methanol reforming under supercritical water conditions. Various parts and equipment were acquired and assembled. The flow diagram for the process is shown below in Figure 1. A mixture of methanol and water is fed to the reactor by means of HPLC pump (Waters 590) after passing through a rupture disc. The pump displays the flow rate and pressure on its panel. The reactor consists of a coil of Inconel 600. (Length of the reactor = 1 m, ID = 0.0426”) The reactor is heated with the help of a tubular furnace with temperature controller (Barnstead Thermolyne, Model 21100). The ends of the tube furnace are insulated properly in order to minimize the heat loss and for the proper control of the temperature. A K-type thermocouple (Omega) measures the reactor temperature just before the exit of the reactor. The reactor is then cooled to 20 °C using a double coiled heat exchanger with cooling water as coolant. Pressure is read using the pressure gauge P. The pressure is then let down using a back-pressure regulator (Straval) which is set at 4000 psi. The vapor and liquid mixture is then separated in the phase separator packed with glass beads. The liquid flow rate measured and its TOC content is measured using a TOC analyzer (▇▇▇▇▇▇-▇▇▇▇▇▇▇▇). The gas phase exiting the phase separator passes through a volumetric flow meter (Omega FMA-1600) which displays flow rate, pressure, temperature and the computer attached to it provides the value for totalized flow. The gas mixture is then sent to a six-port injection valve (Valco) for online injection to the GC. The sample loop has a volume of 100 μL. Helium (BOC gases, 5.0 grade) is used as carrier gas. The gas mixture is fed to a gas chromatograph (Varian 3700) with a TCD detector. The GC contains a carbon molecular sieves packed column. (60/80 Carboxen-1000, Supelco, 15’ x 1/8”) The Peaksimple chromatography data system (SRI, Model 203) converts the analog signal from GC and feeds it to the computer for peak area analysis. The TCD of the GC was calibrated using a gas mixture of known composition. (BOC gases, H2 60%, CO 15%, CO2 20%, CH4 5%). A carbon monoxide detector (Nighthawk) with alarm is installed for safety purpose. T Rupture disc T Cooling water P Heat exchanger HPLC pump Gas flow meter Phase separator Peak analysis on PC Data aquisition system Liquid phase TOC analyzer/ HPLC GC with TCD CO detector with alarm Feed tank (Aqueous MeOH)

Experimental. A variable volume view cell (VVVC) unit (Fig. 1) was used to measure the critical properties of hexane and SCH-FTS mixture. The VVVC unit consists of high-pressure variable volume view cell, manual pressure generator, temperature controller, heating tape, pressure gauge, syringe pump, stirring bar, and stirring plate. The volume of the cell can be adjusted by displacement of an internal movable piston controlled by a manual pressure generator (High Pressure Equipment Model 87-6-5) filled with isopropanol and used to manipulate the pressure in the view cell. The dynamic seal between the piston and the walls of the vessel is achieved by using four Viton O-rings. A video camera (QuickCam Pro 4000) system with a fluorescent ring light was mounted close to the ½`` thick quartz window on the front of the cell. Images of the phase transition from vapor-liquid equilibrium (VLE) to supercritical phase and vice versa were digitally recorded on the PC. The temperature in the cell was measured and controlled with a type PR-11 1/16'' RTD (Omega Engineering) and a self tuning PID controller (Omega CN76030) wired to a magnetic contactor (Omega MC-2-2-40-120), respectively. The cell was heated by using a heavy insulated tape 1/2''×2' (Omega; FGH051) and the accuracy of the measured temperatures was ±0.2 °C. The pressure was measured with a Dynisco flush mount transducer (model TPT-432A) with an accuracy of ±0.5 bar.

Experimental. Materials: 2%, 6% and 10% weight cobalt loaded silica aerogel samples were prepared by ▇▇▇▇. ▇▇▇▇▇▇’▇ lab. Ferrocene and ruthenocene loaded silica aerogel samples were provided by ▇▇▇▇. ▇▇▇▇▇’▇ lab. NMR experiments: All the NMR experiments were carried out on a Chemagnetics CMX-200 spectrometer with a 7.5mm PENCIL rotor probe. The samples were ground into powder before packing into the rotor. Most of the samples were packed at ambient condition except the ferrocene and ruthenocene loaded silica aerogel sample which were packed in a glove box filled with nitrogen gas. A single pulse sequence was applied to observe 29Si NMR spectra, while 13C NMR spectra of the ferrocene and ruthenocene loaded aerogel samples were obtained using CP (cross polarization) and CP/MAS (magic angle spinning) techniques. The 29Si T1 was measured by the saturation recovery method.